Axiom Advisory’s Clorox CLX Stock Holding History

Axiom Advisory’s Portfolio CLX Stock Details CLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$1.68M	Buy	11,328 +177	+2%	+$26.2K	0.02%	128
2024 Q2	$1.55M	Buy	+11,151	New	+$1.55M	0.02%	127

Other funds holding CLX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Axiom Advisory's CLX Position: Q3 2024 in Review

Axiom Advisory increased its Clorox (CLX) stake by 1.6% in Q3 2024, buying an estimated $26.2K and bringing the position to 11,328 shares worth $1.68M. The position accounts for 0.02% of the portfolio, ranked #128.

Axiom Advisory first reported a position in CLX in Q2 2024 and has held it in 2 quarters since. 1,151 funds tracked by Wall St. Rank hold CLX as of Q3 2024.

Axiom Advisory held 11,328 shares of Clorox worth $1.68M as of Q3 2024.
Axiom Advisory bought 177 Clorox shares in Q3 2024, an estimated $26.2K.
Clorox made up 0.02% of Axiom Advisory's portfolio in Q3 2024, its #128 holding.
Axiom Advisory first reported a position in Clorox in Q2 2024 and has held it in 2 quarters since.
1,151 funds tracked by Wall St. Rank held Clorox as of Q3 2024.

Based on Axiom Advisory's 13F filing for Q3 2024, filed 7 Oct 2024.